Role of moesin, Src, and ROS in advanced glycation end product-induced vascular endothelial dysfunction

Area of Science:

• Endothelial Biology
• Diabetic Complications
• Molecular Mechanisms

Background:

• Advanced Glycation End-products (AGEs) are implicated in diabetic micro- and macrovascular complications.
• Endothelial dysfunction, characterized by hyperpermeability and angiogenesis, is a hallmark of diabetes mellitus (DM).
• The role of specific proteins and signaling pathways in AGE-induced endothelial damage requires further elucidation.

Purpose of the Study:

• To review the critical role of moesin in regulating microvascular permeability and angiogenesis.
• To examine the involvement of Src kinase and reactive oxygen species (ROS) in AGE-induced endothelial barrier disruption.
• To highlight potential therapeutic targets for mitigating AGE-mediated endothelial damage.

Main Methods:

• Literature review focusing on molecular and cellular mechanisms.
• Analysis of signaling pathways including Rho/ROCK, p38, and Src.
• Examination of the role of moesin phosphorylation at Thr-558.

Main Results:

• Moesin activation via Thr-558 phosphorylation is central to AGE-induced hyperpermeability and angiogenesis in endothelial cells (ECs).
• Src kinase mediates AGE-induced endothelial barrier dysfunction through phosphorylation of moesin, VE-cadherin, and FAK.
• Reactive oxygen species (ROS) are identified as crucial mediators of the endothelial response to AGEs.

Conclusions:

• Moesin plays a pivotal role in AGE-induced endothelial dysfunction, impacting microvascular permeability and angiogenesis.
• Targeting Src and ROS pathways may offer therapeutic strategies to protect endothelial integrity in diabetes.
• Understanding these molecular pathways is essential for developing interventions against diabetic vascular complications.